Kathryn Borgstrom

Kathryn Borgstrom is a Senior Area General Manager of US Oncology at Bayer, where they focus on bringing innovative oncology therapies to patients and hold full P&L accountability across multiple franchises. With a career that includes roles in field sales, market access, and commercial leadership at companies like Amgen, Roche, and Pfizer, they have successfully led numerous product launches and implemented strategies to enhance patient access. Kathryn thrives at the intersection of strategy and execution, emphasizing team development and collaboration. They hold a Bachelor of Science in Microbiology, Immunology, and Molecular Genetics from the University of California, Los Angeles, and a Master of Arts in Teaching from the University of Southern California.